1. Home
  2. BNED vs VYGR Comparison

BNED vs VYGR Comparison

Compare BNED & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$9.43

Market Cap

284.0M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.82

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNED
VYGR
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.0M
236.0M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
BNED
VYGR
Price
$9.43
$3.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.00
AVG Volume (30 Days)
207.3K
900.2K
Earning Date
03-10-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.39
N/A
Revenue
$1,610,170,000.00
$10,135,000.00
Revenue This Year
N/A
$33.19
Revenue Next Year
N/A
$14.68
P/E Ratio
$24.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$2.65
52 Week High
$12.19
$5.55

Technical Indicators

Market Signals
Indicator
BNED
VYGR
Relative Strength Index (RSI) 60.95 45.04
Support Level $8.22 $3.72
Resistance Level $9.65 $3.85
Average True Range (ATR) 0.42 0.20
MACD 0.05 -0.02
Stochastic Oscillator 89.04 31.57

Price Performance

Historical Comparison
BNED
VYGR

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: